Lyme Disease Epidemic... Genetically Engineered Ticks, CDC Created at Plum Island

Submitted by SadInAmerica on Sun, 08/02/2015 - 6:05pm.


"...we are dealing here with a formidable 'smart stealth' type of bacteria that is hard to eradicate — one that does extreme damage to psyche and soma if not treated aggressively over the long term when missed in the first days following inoculation by the vector...” Dr. Virginia Scherr ~ Jerry Leonard - Free E-Book

The above excerpt from: "Biological Warfare Experiment on American Citizens Results in Spreading Pandemic!" (September, 2011 Public Health Alert)

Researchers have demonstrated the extensive ties between the CDC’s biodefense unit and the perpetuation of the Lyme Epidemic.[1]

Here is a summary of the connections between the Lyme Epidemic and biowarfare:

The causative agent of Lyme disease (Borrelia burgdorferi) was identified by and named after a biowarfare researcher named Willy Burgdorfer, who worked at a biowarfare lab (Rocky Mountain Labs) developing and publishing methods for infecting Ixodid ticks with Borrelia agents—a decade or so before an epidemic caused by Borrelia agents spread by Ixodid ticks broke out just outside a top-level biowarfare lab that did outdoor tick research.[2]

Lyme disease itself is named after Lyme, Connecticut—the town a few miles from a top-level biowarfare lab (Plum Island Animal Disease Research Center) that not only did outdoor tick experiments but also has a history of pathogen leaks.[3]

Plum Island still conducts tick research with African Swine Fever Virus, which, according to papers published by Lyme/biowarfare experts such as Alan Barbour, has “sequence similarities” to segments of DNA in the telomeres of the Borrelia organism which causes Lyme disease.[4]

Plum Island propagates this genetically engineered virus in ticks for vaccine studies. This virus, according to numerous reports, has also reportedly been used by the U.S. in real-world biological warfare attacks.[5]

Lyme disease has properties ideal for a disabling biowarfare agent:[6] rapid dissemination within the body but causing delayed symptoms, relapsing antibiotic resistant infection, protective cyst formation (similar to anthrax), capability for inducing both mental and physical incapacitation[7]

Just as the Lyme spirochete epidemic was getting started, we learned in 1977 of a massive government research effort known as MKULTRA that was "concerned with the research and development of chemical, biological and radiological materials" to do exactly what Lyme does: "severely" incapacitate human victims. [8] [9]

To accomplish this goal, the government engaged in "extensive testing and experimentation" on unwitting human subjects "at all social levels, high and low, native Americans and foreign."[10]

The vector for Lyme disease (Ixodid ticks) was "discovered" by a biowarfare defense expert (Allen Steere) from the CDC's Epidemic Intelligence Service (EIS).[11]

The Lyme bacterium was first propagated in cell cultures by another CDC EIS biowarfare expert (Alan Barbour), in a biowarfare lab.[12]

This researcher had previously studied anthrax for the military,[13] and went on to create mutant strains of Borrelia burgdorferi.[14] He now directs a biowarfare lab at the University of California, Irvine Campus.[15] [16]

As director of the biowarfare lab at University of California, Irvine (The Pacific Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases) Barbour was awarded a research contract by the NIH in 2011 to lead a Lyme vaccine research effort on an island off the coast of the North East of the United States, the location of “ground zero” of the Lyme epidemic and in proximity to the nation’s premier biowarfare test facility that also conducted outdoor tick experiments.[17]

The Lyme Epidemic is being perpetuated by researchers affiliated with the CDC's biowarfare defense unit (EIS), including Steere (EIS) and Eugene Shapiro (EIS) by forcing doctors to treat (or not treat) patients according to treatment guidelines that are so draconian and riddled with self-serving recommendations that the organization that put them out was investigated and reprimanded by the Attorney General of Connecticut. [18]

Gary Wormser is the lead author on the fraudulent treatment guidelines published by the IDSA, which prevent patients from getting effective treatments. (In his spare time, he lectures as an expert on biowarfare agents and treatments: How Germs Become Weapons: Recognizing Agents -- Treating Patients.)

The research study Wormser used to justify his position that Lyme disease is readily cured with short courses of antibiotics was a fraudulent study authored by Mark Klempner, a CDC EIS agent who also now directs a biowarfare lab, at Boston University.

(This celebrated study to allegedly investigate long-term antibiotic treatment of Lyme patients was halted before long-term antibiotics could even be administered.[19])

The first vaccine against the disease was developed and licensed by a defense contractor (Yale Corporation) that worked closely with Plum Island biowarfare lab on biowarfare and vaccine agents.[20]

The lead investigator for the vaccine field trials (Steere) was a Yale and EIS alumnus who has done everything in his power to deny effective antibiotic treatments to Lyme victims, so that the immune response to the disease could be mapped out in untreated controls.

Lyme disease was recently named as a biowarfare agent by the U.S. government. [21]

Consistent with this scenario is a recent publication which traced the catastrophic increase in the host-range and pathogenic nature of the Lyme spirochete, Borrelia burgdorferi, to a recently modified clone:

"In fact, the highly pathogenic ospC-A clone [of Borrelia burgdorferi] seems to have spread rapidly in recent years to infect a broad range of host species ...

We conclude that the ospC-A clone has dispersed rapidly and widely in the recent past. The spread of the ospC-A clone may have contributed, and likely continues to contribute, to the rise of Lyme disease incidence.”

[“Wide Distribution of a High-Virulence Borrelia burgdorferi Clone in Europe and North America,” Emerg Infect Dis. 2008 July; 14(7): 1097–1104.]

Thus, it is not a question whether Lyme is a biowarfare agent. The question is, when was it first investigated as one?

Related questions include:

Where exactly did the "highly pathogenic ospC-A clone" of Borrelia burgdorferi (Lyme disease) which "has dispersed rapidly and widely in the recent past" to "infect a broad range of host species" come from?

Why is a biowarfare researcher who lectured on treatment protocols for the anthrax biowarfare agent that, according to the FBI, somehow escaped Fort Detrick the week of 9-11 also the lead author on the treatment protocols for a different biowarfare agent that appears to have escaped from Fort Detrick's outdoor test lab at Plum Island years earlier?

If it were not a biowarfare agent, what are the odds that an Ixodid tick-borne Borrelia disease agent that has been identified by the government as a biowarfare agent, would be named after a biowarfare researcher who published methods for infecting Ixodid ticks with Borrelia agents inside a biowarfare lab?

What are the odds a Borrelia disease spread by ticks, that broke out just outside a biowarfare lab that conducted tick research, is not a biowarfare agent?

What are the odds that treatment denial for this disease agent, which is orchestrated by various agents of the biowarfare wing of an agency that conducted experiments limiting treatment for a similar disease agent (both the Lyme Borrelia and syphilis are classified as spirochetes), is not part of a similar experiment conducted on a grander scale, this time under the protection of biowarfare research?[22]

It has been said that the first rule of biowarfare is that a disease agent is never released by a government unless the government has a cure, to protect the non-targeted populations.

Since Lyme is obviously being allowed to spread internationally by agents of the American biowarfare infrastructure, this gives hope that a cure for Lyme disease does indeed exist, but is being selectively applied (for example, to the politicians who get Lyme disease).

Thus, further investigation into the biowarfare roots of Lyme disease may reveal this cure.

The white-coated, blood-sucking parasites in the national security infrastructure are clearly not going to reveal the secrets about the blood sucking, Lyme-infected parasites they have unleashed on the world. This would open them up to charges of crimes against humanity.

Consequently, Lyme patients must demand answers to these questions if they are to prevent this epidemic from creating an even greater public health disaster (including contamination of the blood supply by the difficult-to-detect disease agent) from which we may never recover.

"The number of Steere camp Lyme researchers with a background in the Epidemic Intelligence Service (EIS) and/or biowarfare research is too numerous to be pure coincidence.

Two scientists who have played a central role in the Lyme story, Barbour and Klempner, have been placed in charge of new biowar super-labs set up in the aftermath of 9-11, where they are aided by some of their Steerite colleagues.

Others, while not in charge of super-labs, are nevertheless in receipt of substantial grants for biowarfare research."

-- Elena Cook, “Lyme Is A Biowarfare Issue”

August 2, 2015 -


* Jerry Leonard is a Lyme Disease victim and author.

He has written three books on unethical medical experiments conducted by the government -- including experiments involving the systematic injection of tumor cells and monkey cancer virus in humans so that model forms of cancer could be induced and maintained in human subjects for vaccine research. For an overview of Jerry’s work, see...

America’s Secret Weapons:
Contact Jerry at


See Elena Cook’s article Elena Cook's "Lyme Is A Biowarfare Issue":

[2] The film-makers for Lyme disease documentary Under Our Skin, relate the bizarre story of what happened when they tried to interview Willy Burgdorfer, the biowarfare researcher for whom the Lyme disease agent is named:

“Just as we began filming, there was a pounding on the door, and we found ourselves facing someone who turned out to be a top researcher at the nearby Rocky Mountain Laboratories, a biolevel-4 NIH research facility.

Standing on the porch, our uninvited guest said, “I’ve been told that I need to supervise this interview. This comes from the highest levels. There are things that Willy can’t talk about.”

“We were stunned. After all, Dr. Burgdorfer had been retired from the lab since 1986. We were there to talk to a private citizen, about the history of a very public discovery that had put him on the short list for a Nobel Prize.

Earlier that year, the NIH had refused our requests to interview any of their Lyme researchers. What was going on? Why would the NIH want to censor information about the fastest growing bug-borne disease in the United States?’

“Lyme discoverer Willy Burgdorfer breaks silence on heated controversy,”

The New York Times reported that one virus alone has escaped the Plum Island lab environs at least two times. One was the day before a visit by New York politicians. A previous escape occurred in 1978, just as the Lyme epidemic was getting underway:

“The Department of Homeland Security confirmed last week that the highly contagious foot-and-mouth virus had briefly spread within the Plum Island Animal Disease Center in two previously undisclosed incidents earlier this summer.

“The first incident, which involved two head of cattle, occurred one day before government officials and visitors came to the island on June 25 to celebrate the laboratory's 50th anniversary. …

“In 1978, a foot and mouth outbreak among animals in pens outside the laboratory resulted in new procedures for keeping animals used in research inside the biocontainment area.”

John Rather, “Plum Island Reports Disease Outbreak,” New York Times, Aug. 22, 2004.

[4] “When the borrelia telomeres were compared with telomeric sequences of other linear double-stranded DNA replicons, sequence similarities were noted with poxviruses and particularly with the iridovirus agent of African swine fever.

The latter virus and a Borrelia sp. share the same tick vector. These findings suggest that the novel linear plasmids of Borrelia originated through a horizontal genetic transfer across kingdoms.”

[Did this horizontal genetic transfer have any human assistance?]
J. Hinnebusch and A.G. Barbour, J Bacteriol. November 1991; 173(22): 7233–7239.

The virus has been identified as one used in real-world biological warfare exercises against Cuba. “CIA Link to Cuban, Pig Virus Reported,” San Francisco Chronicle, Jan. 10, 1977,

[6] As summarized by Mark Sanborne:

“Lyme’s ability to evade detection on routine medical tests, its myriad presentations which can baffle doctors by mimicking 100 different diseases, its amazing abilities to evade the immune system and antibiotic treatment, would make it an attractive choice to bioweaponeers looking for an incapacitating agent.

Lyme’s abilities as ‘The Great Imitator’ might mean that an attack could be misinterpreted as simply a rise in the incidence of different, naturally occurring diseases such as autism, MS, lupus and chronic fatigue syndrome (M.E.).

Borrelia’s inherent ability to swap outer surface proteins, which may also vary widely from strain to strain, would make the production of an effective vaccine extremely difficult. ...

Finally, the delay before the appearance of the most incapacitating symptoms would allow plenty of time for an attacker to move away from the scene, as well as preventing people in a contaminated zone from realising they had been infected and seeking treatment.”

Mark Sanborne, “The Mystery of Plum Island: Nazis, Ticks and Weapons of Mass Infection”

In addition to weapons that could kill quickly, the Pentagon was interested in weapons that could incapacitate—like Rift Valley Fever. Michael Carroll relates in his book Lab 257:

“Pentagon scientists briefed President Dwight D. Eisenhower on using Rift Valley Fever as a nonlethal biological weapon that would ‘incapacitate’ the enemy, rather than kill him. Used correctly, it could deter and demoralize the enemy and, at the same time, spare buildings and infrastructure from incendiary bombs.

The president approved funding in this new area of weaponry, calling it a ‘splendid idea.’ Research on incapacitating germ agents began.”

According to congressional sources on the nature of the MKULTRA research: "Its purpose was to stockpile severely incapacitating and lethal materials."

As described in one study: "The MKULTRA activity is concerned with the research and development of chemical, biological and radiological materials capable of employment in clandestine operations to control human behavior."

This behavior included discrediting behaviors and the ability to induce mental and physical incapacitation.

[9] Much has been written about the chemical and radiation experiments that were conducted as part of MKULTRA. Very little has been written about the infectious disease agents that were developed for mental incapacitation.

[10] It is hard to overestimate the scale of this experimentation, or the level of participation among the nation’s leading academics and scientists in the search for mentally incapacitating and controlling agents. Dr. Collin Ross states:

“The participation of psychiatrists and medical schools in mind-control research was not a matter of a few scattered doctors pursuing questionable lines of investigation. Rather, the mind-control experimentation was systematic, organized and involved many leading psychiatrists and medical schools.

The mind-control experiments were interwoven with radiation experiments and research on chemical and biological weapons. They were funded by the CIA, Army, Navy, Air Force and by other agencies including the Public Health Service and the Scottish Rite Foundation.

The psychiatrists, psychologists, neurosurgeons and other contractors conducting the work were imbedded in a broad network of doctors, and much of the research was published in medical journals. The climate was permissive, supportive and approving of mind-control experimentation.”

Actually it was discovered by one of his patients, Joe Dowhan, who presented Steere with the tick that bit him prior to his development of Lyme symptoms. Dowhan had even saved the tick, which turned out to be from the Ixodes Scapularis species. Murray, p. 157.

Barbour wrote of bizarre human experiments for syphilis cures in which human subjects were infected with borrelia agents after they were passaged through mice... 

“When using borreliae for pyrotherapy of neurosyphilis, the authors of this report recommended that no more than 30 to 40 passages in mice be made before inoculation of the strain back into humans.”

Alan G. Barbour and Stanley F. Hayes, “Biology of Borrelia Species, Microbiological Reviews,” December 1986, p. 381-400.

H.B. Rees, Jr., M.A. Smith , J.C. Spendklove, R.S. Fraser, T. Fukushima, A.G. Barbour, Jr. and F. J. Schoenfeld, “Epidemiologic and Laboratory Investigations of Bovine Anthrax in Two Utah Counties in 1975,” Public Health Reports, March-April 1977, Vol. 92, No. 2 177.

[14] Ariadna Sadziene, D. Denee Thomas, Virgilio G. Bundoc, Stanley C. Holt and Alan G. Barbour, “A Flagella-less Mutant of Borrelia burgdorferi,” J. Clin. Invest., Volume 88, July 1991, 82-92.

[15] "The Pacific Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (PSW RCE) was funded in May, 2005 by the National Institute of Allergies and Infectious Diseases (NIAID).

The PSW RCE serves Region IX and is one of ten nationally funded Centers which support the NIAID Biodefense and Emerging Infectious Diseases Research Agenda."

[16] From an article on the Pacific-Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, in Homeland Security News, quoting Dr. Barbour: “The center’s main objective, he said, is to provide the science for creating a defense against emerging diseases, like dengue fever, and potential bioterrorism agents, like the botulism toxin.”

“UCI Awarded $45 Million for Infectious Disease Research, May 13, 2009.

Abstract Text: ‘Our long-term goal is sustainable reduction of the incidence of Lyme borreliosis (LB). We propose to achieve this safely and inexpensively by targeting vaccines to the reservoir hosts of the agent Borrelia burgdorferi.

Building upon our proof-of-concept studies and extending the work's scope to include further definition of the key reservoir species, we will develop live attenuated vaccines for oral delivery in the field and initiate controlled vaccine trials at field sites.

The field studies will also inform implementation of a reservoir-targeted plague vaccine (Project 7.3). This is a multidisciplinary, multi-institution translational research project.

Specific aim 1 is further development of a vaccine that uses the vaccinia virus backbone of the commercial rabies vaccine to express OspA of B. burgdorferi and to (a) administer this to a major reservoir, the white-footed mouse, Peromyscus leucopus, and (b) evaluate different methods of field delivery of the vaccine.

Contact Principal Investigator: BARBOUR, ALAN G.’

Quoting Attorney General Richard Blumenthal: “We issued a subpoena to the IDSA because its guidelines may severely constrict choices and legitimate diagnosis and treatment options for patients.”

As it turns out, the IDSA panel was riddled with conflicts of interest as well as military agents of the CDC’s EIS. This might explain why the panel’s “voluntary” treatment guidelines were immediately picked up by the CDC’s website.

It may also explain why the board’s increasingly narrow-minded treatment protocols have been used to target doctors for elimination because they choose to treat Lyme disease according to the best-known methods instead of according to the IDSA’s so-called “voluntary guidelines.”

EIS doctors also testify at the medical board trials of doctors who treat against EIS-authored guidelines.

“After a planned interim analysis, the … monitoring board recommended that the studies be discontinued because data from the … patients indicated that it was highly unlikely that a significant difference in treatment efficacy between the groups would be observed…”

Mark S. Klempner, et al, “Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease,” New England Journal of Medicine,; 345:85-92, July 12, 2001.

Yale personnel worked hand-in-glove with Plum Island on the Rift Valley Fever virus and also with Fort Detrick on vaccines against this incapacitating disease agent, even helping conduct human experiments with them as part of Operation Whitecoat.

An article was put out by the Associated Press mentioning the study of Lyme disease at a new biowarfare lab at the University of Texas, San Antonio. The article was quickly retracted and mention of Lyme disease was scrubbed from the article.

Here is the text of the original article: “A new research lab for bioterrorism opened Monday at the University of Texas at San Antonio. The $10.6 million Margaret Batts Tobin Laboratory Building will provide a 22,000-square-foot facility to study such diseases as anthrax, tularemia, cholera, lyme disease, desert valley fever and other parasitic and fungal diseases.

The Centers for Disease Control and Prevention identified these diseases as potential bioterrorism agents.” MSNBC, 11/21/2005. For a comparison of the censored and uncensored articles, see:

Tina Garcia has reported: “Three well-known researchers, who have studied Lyme disease for many years, are currently biowarfare lab directors.

Their names are Dr. Alan G. Barbour, Director of the Pacific-Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases at the University of California Irvine, Dr. Duane J. Gubler, Director of the Asia-Pacific Institute of Tropical Medicine and Infectious Diseases at the University of Hawaii, and Dr. Mark S. Klempner, Director of the National Emerging Infectious Diseases Laboratories at Boston University.”

Tina J. Garcia, “Biowarfare Lab Directors Are Experts on Lyme Disease, a Level II Debilitating Biological Agent,” Nov. 24, 2010,;read=189403

[23] The borrelia agent that causes Lyme disease was named Borrelia burgdorferi (or Bb) after Willy Borgderfer and other Rocky Mountain Lab researchers published the first papers on it. See: Burgdorfer W, Barbour A.G., Hayes S.F., Benach J.L., Grunwaldt E, and Davis J.P., "Lyme disease-a tick-borne spirochetosis?," Science, June 18, 1982;216(4552):1317-9.

[24] Burgdorfer forced a relapsing fever borrelia known as B. Latchevi, found naturally in an argasid tick species known as O. tartakovskyi, to infect a species of tick known as O. moubata, which had been transported to the Rocky Mountain lLab from the Congo.

Burgdorfer fed the moubata ticks on mice that had been infected with the borrelia by the borrelia’s natural host O. tartakovskyi. Serial passage of the borrelia was carried out by injecting other mice with the blood of the tick-infected mice.

Attempts were then made to infect other lab animals by allowing the newly infected tick species under study, O. moubata, to feed on infected mice and then healthy mice and rabbits.

It was found that the moubata tick could be readily infected through diseased animals but could not pass the infection on to the healthy animals by feeding on them.

Burgdorfer, W, and Davis, G.E., "Experimental infection of the African relapsing fever tick, Ornithodoros moubata (Murray), with Borrelia latychevi (Sofiev)," J Parasitol. August 1954; 40(4):456-60.

[25] Burgdorfer, W., "On the 'Occult' Infection in Relapsing Fevers," Bull. Soc. Pathol. Exot., 1954; 47: 664-667.

[26] "The described feeding technique provides an excellent artifice for experimental infection of Ixodid ticks with viruses or other pathogens. To a great extent it eliminates the use of expensive laboratory animals which in the past had to serve as blood donors for the infection of these arthropods.

Because of irregular feeding habits of the Ixodidae, it is impossible to obtain uniformly infected ticks for experimental studies, a difficulty which can be overcome by use of the technique here described. ...

This technique, furthermore, is of great value in studies on the transmission of disease agents." Willy Burgdorfer, "Artificial Feeding of Ixodid Ticks for Studies on the Transmission of Disease Agents," J Infect Dis. , May-Jun 1957;100(3):212-4.

[27] “The results suggest that B. burgdorferi in its animal hosts and possibly also in humans causes prolonged spirochetemias characterized by episodes of alternating high and low concentrations of spirochetes as reflected by similar percentages of infected ticks.

The long persistence of spirochetes in the peripheral blood stream and the cyclical form of Lyme borreliosis appear to be related, as in relapsing fevers, to the capacity of B. burgdorferi to undergo antigenic variations.” Willy Burgdorfer,W and T.G. Schwan, "Lyme Borreliosis: A Relapsing Fever-Like Disease?," Scand J Infect Dis Suppl. 1991;77:17-22.

[28] “The causes of Rocky Mountain spotted fever and Lyme disease were discovered at RML.” Carlotta Grandstaff, "Bush’s War on Terrorism Comes West,",


[30] Lab 257, Michael Carroll.

[31] “Throughout his career, Dr. Burgdorfer participated in a number of WHO and other health organization-sponsored seminars and congresses. From 1967-1972, he served as associate member on the Rickettsial Commission of the Armed Forces Epidemiology Board.

For several years (1968-1971) he was also co-project officer of the PL 480-sponsored Research Project on Rickettsial Zoonoses in Egypt and adjacent areas, and from 1979 to 1986, he directed the WHO-sponsored Reference Center for Rickettsial Diseases at RML in Montana, U.S.A.” Source:



Tag this page!
Submitted by SadInAmerica on Sun, 08/02/2015 - 6:05pm.